Chest Pain Unit II Register

Chest Pain Unit II Register - CPU II Register

Multicentric, prospective, non-interventional observational study with two parts:

  1. A register of quality assurance within the recertification of clinics
  2. An extended register with scientific protocol.

Study Overview

Status

Completed

Conditions

Detailed Description

  1. Quality assurance

    As a quality-assuring basic register, the CPU II register checks the extent to which certified Chest Pain Units fulfill the criteria published by the DGK. In particular, the following quality dimensions are evaluated:

    • Indication quality
    • Diagnostic quality
    • Therapeutic quality
    • Structural quality / networking
  2. Platform for projects with a scientific focus

The CPU II register and the infrastructure provided are a platform for further projects with scientific questions (scientific protocol = WP):

WP: Clinical history after CPU (PCI data / discharge / 12-month FUP) in patients with leading cardiac diagnosis

Study Type

Observational

Enrollment (Actual)

4829

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bremen, Germany, 28277
        • Klinikum Links der Weser Bremen
    • Bayern
      • Munchen, Bayern, Germany, 81737
        • Städtisches Klinikum Neuperlach
    • RLP
      • Mainz, RLP, Germany, 55131
        • Klinikum der Johannes-Gutenberg-Universität, 2. Med. Klinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Basic register:

All patients who are admitted to a CPU.

Scientific Protocol:

All patients who are admitted to a CPU and have their consent to participate in a follow-up (in patients with leading cardiac diagnosis).

Description

Inclusion Criteria:

  • CPU patient
  • > 18 years
  • Written consent of the patient

Exclusion Criteria:

  • Denied consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fulfillment of DGK criteria
Time Frame: 12 months
Quality assurance: Fulfillment of the recertification criteria of the german society for cardiology
12 months
Clinical progress after CPU
Time Frame: 12 months
Scientific protocol: Documentation of the clinical progress after CPU
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

March 21, 2017

First Submitted That Met QC Criteria

March 21, 2017

First Posted (Actual)

March 27, 2017

Study Record Updates

Last Update Posted (Actual)

August 5, 2020

Last Update Submitted That Met QC Criteria

August 4, 2020

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CPU II Register

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe